UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 109

Sortiert nach

Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovani

Antimicrobial Agents and Chemotherapy, 2004-08, Vol.48 (8), p.3010-3015

2004

Volltextzugriff (PDF)

In vivo inhibition of focal adhesion kinase causes insulin resistance

The Journal of physiology, 2008-08, Vol.586 (16), p.3825-3837

2008

Volltextzugriff (PDF)

CDK5 inhibition improves glucose uptake in insulin‐resistant neuronal cells via ERK1/2 pathway

Cell biology international, 2022-03, Vol.46 (3), p.488-497

2022

Volltextzugriff (PDF)

1790-P: Akt2 Is Required for Glucose Uptake in Neuronal Insulin Signaling In Vitro

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1789-P: Ser/Thr Phosphatase-PP2C Negatively Regulates AS160 and GSK3β Activity in Neuronal Insulin Signal Transduction Pathway

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

1787-P: Protein Kinase C (PKC) Negatively Regulate Neuronal Insulin Signaling In Vitro

Diabetes (New York, N.Y.), 2019-06, Vol.68 (Supplement_1)

2019

Volltextzugriff (PDF)

Nuclear co‐repressor (NCoR) is required to maintain insulin sensitivity in C2C12 myotubes

Cell biology international, 2017-02, Vol.41 (2), p.204-212

2017

Volltextzugriff (PDF)

Nuclear co-repressor (NCoR) is required to maintain insulin sensitivity in C 2 C 12 myotubes

Cell biology international, 2017-02, Vol.41 (2), p.204-212

2017

Volltextzugriff (PDF)

P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

Pharmacological research, 2003-10, Vol.48 (4), p.347-359

2003

Volltextzugriff (PDF)

Metformin enhances insulin signalling in insulin‐dependent and ‐independent pathways in insulin resistant muscle cells

British journal of pharmacology, 2002-10, Vol.137 (3), p.329-336

2002

Volltextzugriff (PDF)

Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani

Acta tropica, 2007-09, Vol.103 (3), p.172-185

2007

Volltextzugriff (PDF)

Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction

Experimental parasitology, 2007-05, Vol.116 (1), p.1-13

2007

Volltextzugriff (PDF)

Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK

Pharmacological reports, 2011, Vol.63 (5), p.1162-1168

2011

Volltextzugriff (PDF)

Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells

Biochemical pharmacology, 2003-01, Vol.65 (2), p.249-257

2003

Volltextzugriff (PDF)

PPAR‐γ expression modulates insulin sensitivity in C2C12 skeletal muscle cells

British journal of pharmacology, 2004-12, Vol.143 (8), p.1006-1013

2004

Volltextzugriff (PDF)

Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A)

International journal of antimicrobial agents, 2008-06, Vol.31 (6), p.584-586

2008

Volltextzugriff (PDF)

Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani

Molecular and biochemical parasitology, 2005-05, Vol.141 (1), p.57-69

2005

Volltextzugriff (PDF)

Evidence for the presence of R250G mutation at the ATPase domain of topoisomerase II in an arsenite-resistant Leishmania donovani exhibiting a differential drug inhibition profile

International journal of antimicrobial agents, 2009-01, Vol.33 (1), p.80-85

2009

Volltextzugriff (PDF)

Proteomic analysis of wild type and arsenite-resistant Leishmania donovani

Experimental parasitology, 2009-12, Vol.123 (4), p.369-376

2009

Volltextzugriff (PDF)

Arsenite resistance in Leishmania and possible drug targets

Advances in experimental medicine and biology, 2008, Vol.625, p.1

2008

Volltextzugriff (PDF)

Focal Adhesion Kinase contributes to insulin-induced actin reorganization into a mesh harboring Glucose transporter-4 in insulin resistant skeletal muscle cells

BMC cell biology, 2008-09, Vol.9, p.48

2008

Volltextzugriff (PDF)

Subtype specific roles of mitogen activated protein kinases in L6E9 skeletal muscle cell differentiation

Molecular and cellular biochemistry, 2002-09, Vol.238 (1-2), p.27-39

2002

Volltextzugriff (PDF)

Involvement of c-Jun N-terminal kinase activities in skeletal muscle differentiation

Journal of muscle research and cell motility, 2004-11, Vol.25 (8), p.645-655

2004

Volltextzugriff (PDF)

Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells

Journal of experimental biology, 2002-12, Vol.205 (Pt 23), p.3739-3746

2002

Volltextzugriff (PDF)

Involvement of Elk‐1 in L6E9 skeletal muscle differentiation

FEBS letters, 2002-09, Vol.527 (1-3), p.119-124

2002

Volltextzugriff (PDF)

1 – 25 von 109

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(103)
Mit Volltextzugriff
(101)

Publikationsform

Sprache

Englisch
(109)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Possible Mechanism of Miltefosine-Mediated Death of Leishmania donovani

In vivo inhibition of focal adhesion kinase causes insulin resistance

CDK5 inhibition improves glucose uptake in insulin‐resistant neuronal cells via ERK1/2 pathway

1790-P: Akt2 Is Required for Glucose Uptake in Neuronal Insulin Signaling In Vitro

1789-P: Ser/Thr Phosphatase-PP2C Negatively Regulates AS160 and GSK3β Activity in Neuronal Insulin Signal Transduction Pathway

1787-P: Protein Kinase C (PKC) Negatively Regulate Neuronal Insulin Signaling In Vitro

Nuclear co‐repressor (NCoR) is required to maintain insulin sensitivity in C2C12 myotubes

Nuclear co-repressor (NCoR) is required to maintain insulin sensitivity in C 2 C 12 myotubes

P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement

Metformin enhances insulin signalling in insulin‐dependent and ‐independent pathways in insulin resistant muscle cells

Induction of apoptosis-like cell death by pentamidine and doxorubicin through differential inhibition of topoisomerase II in arsenite-resistant L. donovani

Miltefosine induces apoptosis in arsenite-resistant Leishmania donovani promastigotes through mitochondrial dysfunction

Potentiation of neuronal insulin signaling and glucose uptake by resveratrol: the involvement of AMPK

Development of insulin resistance and reversal by thiazolidinediones in C2C12 skeletal muscle cells

PPAR‐γ expression modulates insulin sensitivity in C2C12 skeletal muscle cells

Proteomic analysis of miltefosine-resistant Leishmania reveals the possible involvement of eukaryotic initiation factor 4A (eIF4A)

Novobiocin induces apoptosis-like cell death in topoisomerase II over-expressing arsenite resistant Leishmania donovani

Evidence for the presence of R250G mutation at the ATPase domain of topoisomerase II in an arsenite-resistant Leishmania donovani exhibiting a differential drug inhibition profile

Proteomic analysis of wild type and arsenite-resistant Leishmania donovani

Arsenite resistance in Leishmania and possible drug targets

Focal Adhesion Kinase contributes to insulin-induced actin reorganization into a mesh harboring Glucose transporter-4 in insulin resistant skeletal muscle cells

Subtype specific roles of mitogen activated protein kinases in L6E9 skeletal muscle cell differentiation

Involvement of c-Jun N-terminal kinase activities in skeletal muscle differentiation

Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells

Involvement of Elk‐1 in L6E9 skeletal muscle differentiation

Suchergebnisse filtern